EPS Corporation   Report issue

For profit Phase 2 Phase 3
Founded: Tokyo Japan (1991)

Organization Overview

First Clinical Trial
2012
NCT01762501
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

EPS Corporation | EPS International | Sogo Rinsho Médéfi Co., Ltd.